Chylomicron Remnant Concentrations in Patients with Coronary Artery Disease : Clinical Chemistry and Laboratory Medicine uses cookies, tags, and tracking settings to store information that help give you the very best browsing experience.
To understand more about cookies, tags, and tracking, see our Privacy Statement
I accept all cookies for the De Gruyter Online site

Jump to ContentJump to Main Navigation

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Schlattmann, Peter / Tate, Jillian R. / Tsongalis, Gregory J.

IMPACT FACTOR 2014: 2.707
Rank 6 out of 30 in category Medical Laboratory Technology in the 2014 Thomson Reuters Journal Citation Report/Science Edition

SCImago Journal Rank (SJR) 2014: 0.741
Source Normalized Impact per Paper (SNIP) 2014: 1.011
Impact per Publication (IPP) 2014: 2.310



30,00 € / $42.00 / £23.00

Get Access to Full Text

Chylomicron Remnant Concentrations in Patients with Coronary Artery Disease

Matthias Orth / Jutta Dierkes / Claus Luley

Citation Information: Clinical Chemistry and Laboratory Medicine. Volume 41, Issue 5, Pages 652–662, ISSN (Print) 1434-6621, DOI: 10.1515/CCLM.2003.099, June 2005

Publication History

Published Online:


Persisting chylomicron remnants have been linked to premature atherosclerosis. The analysis of chylomicron remnant concentrations by an oral triglyceride tolerance test, however, is time-consuming for the study subjects and requires large resources in the laboratory. Therefore, only small numbers of subjects have been studied in the past. The aim of this study was to elucidate the prevalence of elevated chylomicron remnants, to identify effectors of chylomicron remnant clearance and to compare chylomicron remnants in the prediction of coronary artery disease with other risk factors. We applied a novel oral triglyceride tolerance test to 423 patients (368 males, 55 females) with a confirmed diagnosis of coronary artery disease (CAD) and to 390 control subjects (295 males, 95 females) in a case-control setting. This study revealed that elevated chylomicron remnant concentrations (retinyl esters >1.5 μmol/l) are present in 20% of all subjects. Male gender, the apolipoprotein E2 isoform, and higher body mass index were associated with increased chylomicron remnant concentrations. However, chylomicron remnants were lower and plasma triglycerides higher in patients with CAD. We conclude that screening for a delayed clearance of chylomicron remnants is of little clinical value in CAD.

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

René Valero, Anne-Marie Lorec, Franck Paganelli, Sophie Beliard, Catherine Atlan, Denis Lairon, Bernard Vialettes, and Henri Portugal
Metabolism, 2005, Volume 54, Number 11, Page 1442
Genovefa D. Kolovou, Katherine K. Anagnostopoulou, Nektarios D. Pilatis, Mirto Giannopoulou, Ioannis S. Hoursalas, Antonis N. Pavlidis, Evdokia Adamopoulou, Alexandra I. Valaora, Dimitri P. Mikhailidis, and Dennis V. Cokkinos
Journal of Women's Health, 2004, Volume 13, Number 10, Page 1119

Comments (0)

Please log in or register to comment.